Skip to main content
. 2019 Jan 15;12(3):561–575. doi: 10.1016/j.tranon.2018.12.011

Table 1.

Comparison of the Clinical-Pathological Characteristics of the Breast Tumor Cohorts.

Total (n=768) ER+ (n=447) ER−, Nonbasal (n=193) ER−, Basal (n=128) P Value
Patient age
 Median 65 68 56 57.5
Tumor grade # cases % # cases % # cases % # cases %
 0-5 34 6 21 6 9 7 4 8 <.0001
 6-7 362 66 298 82 53 39 11 23
 8-10 151 28 44 12 74 54 33 69
Nodal status
 +ve 356 46.8% 204 45.6% 92 48.8% 60 48.4% .7275
 −ve 404 53.2% 243 54.4% 98 51.2% 63 51.6%
Tumor size
 >2.5 cm 301 48% 195 45% 26 50% 80 56% .0589
 <=2.5 cm 331 52% 242 55% 26 50% 63 44%
Claudin 1 (H-score) # cases median # cases median # cases median # cases median <.0001
643 30 371 15 164 70 108 62.50
PKCα (intensity) # cases % # cases % # cases % # cases %
 1 387 73.6% 307 73.6% 31 77.5% 49 71.0% .7595
 2, 3 139 26.4% 110 26.4% 9 22.5% 20 29.0%
PKCε (intensity) # cases % # cases % # cases % # cases %
 1 449 69.0% 259 64.9% 112 71.8% 78 81.3% <.01
 2, 3 202 31.0% 140 35.1% 44 28.2% 18 18.8%
Recurrence (5 years) 32.0% 22.8% 50.3% 37.5% <.001
Survival (5 years) 76.5% 89.0% 54.5% 65.4%